Financials
Financial year 2025
PHARMACIE BOREUX from Saint-Ghislain, company number BE0543901962, closed financial year 2025 with a result of € -47,134 after tax. For that financial year PHARMACIE BOREUX recorded a gross margin of € 464,952 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 163,028 to € -47,134. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 1.3 million
▼ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -47,134
▼ still € 163,028 profit in 2024
Profit after tax over the fiscal year.
€ 111,802
▲ € 109,964 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 1.2 million.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 184,283
€ 61,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 42,753
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 750,166
▲ 111% vs 2024
€ 167,899 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 57,680
▲ € 54,853 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,794
▲ € 30,994 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 96,258 | € 97,954 | € 98,460 | € 464,952 | ▲ € 366,492 |
| Profit after taxes | € 140,013 | € 179,832 | € 163,028 | € -47,134 | ▼ € 210,162 |
| Equity | € 1,051,766 | € 1,182,598 | € 1,345,626 | € 1,258,491 | ▼ 6% |
| Total debts | € 664,141 | € 525,907 | € 361,824 | € 873,089 | ▲ 141% |
| Cash | € 22,730 | € 16,051 | € 1,839 | € 111,802 | ▲ € 109,964 |
| Land & buildings | - | - | - | € 215,489 | |
| Retained profit | € 991,766 | € 1,122,598 | € 1,285,626 | € 1,198,491 | ▼ 7% |
| Dividend | € 40,000 | € 49,000 | € 0 | € 40,000 | |
| Bank debt | € 588,475 | € 471,176 | € 354,797 | € 750,166 | ▲ 111% |
| Balance sheet total | € 1,715,907 | € 1,708,504 | € 1,707,449 | € 2,131,580 | ▲ 25% |
| Employees (FTE) | - | - | - | 3 |
Key figures of PHARMACIE BOREUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE BOREUX?
What happened at PHARMACIE BOREUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 47,134 (▼ € 210,162 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Saint-Ghislain. KBO
In short
From € 140,013 profit in 2022 to € 47,134 loss in 2025.
Paid € 78,796 in corporate taxes since 2022.
Best year ever: 2023, with € 179,832 profit.
On average € 155,000 of value added per employee in 2025.
A new publication or filing at PHARMACIE BOREUX? We notify you, reason included.
Follow PHARMACIE BOREUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE BOREUX is Caroline Allaerts. Caroline Allaerts is also behind PHARMACIE BOREUX.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue du Peuple(T) 36
7333 Saint-Ghislain
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0543.901.962
- VAT number
- BE 0543.901.962
- Registered office
- Rue du Peuple(T) 36, 7333 Saint-Ghislain
- Names & denominations
- PHARMACIE BOREUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 January 2014
- Peppol
- Active · Active since 17 Feb 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen